Serial Number 97628792
Registration 7086995
700

Registration Progress

Application Filed
Oct 12, 2022
Under Examination
Approved for Publication
Apr 4, 2023
Published for Opposition
Apr 4, 2023
Registered
Jun 20, 2023

Trademark Image

Basic Information

Serial Number
97628792
Registration Number
7086995
Filing Date
October 12, 2022
Registration Date
June 20, 2023
Published for Opposition
April 4, 2023
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 20, 2023
Registration
Registered
Classes
005

Rights Holder

Sun Pharmaceutical Industries Limited

16
Address
Sun House, Plot No. 201 B/1
Western Express Highway, Goregaon - East
Mumbai, Maharashtra 400063
IN

Ownership History

Sun Pharmaceutical Industries Limited

Original Applicant
16
Mumbai, Maharashtra IN

Sun Pharmaceutical Industries Limited

Owner at Publication
16
Mumbai, Maharashtra IN

Sun Pharmaceutical Industries Limited

Original Registrant
16
Mumbai, Maharashtra IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
1439 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-20)
Due Date
June 20, 2029
Grace Period Ends
December 20, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description
Jun 20, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Jun 20, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 4, 2023 PUBO A PUBLISHED FOR OPPOSITION
Apr 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 27, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2023 DOCK D ASSIGNED TO EXAMINER
Oct 27, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; intestinal disorder medicine for the treatment of ulcerative colitis; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of cancer
First Use Anywhere: Sep 28, 2018
First Use in Commerce: Sep 28, 2018

Additional Information

Design Mark
The mark consists of purple, blue and yellow wavy bands.
Color Claim
The color(s) purple, blue and yellow is/are claimed as a feature of the mark.

Classification

International Classes
005